More big money from pharmaceutical lobby in 2008

By

 Updated:

The economy may be sliding, but that hasn’t stemmed the high-rolling habits of Washington’s largest lobby. In 2007, as the Center recently reported, the pharmaceutical industry — along with makers of medical devices and other health products — spent a record $189 million-plus on federal lobbying. Though the industry is not quite on track to meet that total this year, just-released disclosure reports show the lobby has already spent a still-impressive $40 million in the first quarter of 2008.

Leading the pack again this year: the trade group Pharmaceutical Research & Manufacturers of America, with $3.6 million in expenses. Also among the big spenders are industry heavyweights Eli Lilly and Co., Pfizer Inc., Amgen Inc., and Roche Holding AG.

Care about freedom of the press? Support independent investigative journalism.

Donate now
Donate now